Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Strata Critical Medical (SRTAW) EBT Margin (2020 - 2025)

Historic EBT Margin for Strata Critical Medical (SRTAW) over the last 6 years, with Q3 2025 value amounting to 19.59%.

  • Strata Critical Medical's EBT Margin fell 39900.0% to 19.59% in Q3 2025 from the same period last year, while for Sep 2025 it was 11.42%, marking a year-over-year increase of 162500.0%. This contributed to the annual value of 11.08% for FY2024, which is 144700.0% up from last year.
  • As of Q3 2025, Strata Critical Medical's EBT Margin stood at 19.59%, which was down 39900.0% from 5.26% recorded in Q2 2025.
  • Over the past 5 years, Strata Critical Medical's EBT Margin peaked at 23.61% during Q2 2022, and registered a low of 73.64% during Q4 2023.
  • Over the past 5 years, Strata Critical Medical's median EBT Margin value was 16.59% (recorded in 2024), while the average stood at 21.83%.
  • Its EBT Margin has fluctuated over the past 5 years, first plummeted by -616100bps in 2021, then soared by 836100bps in 2022.
  • Quarter analysis of 5 years shows Strata Critical Medical's EBT Margin stood at 2.69% in 2021, then plummeted by -1682bps to 42.59% in 2022, then crashed by -73bps to 73.64% in 2023, then soared by 82bps to 13.62% in 2024, then tumbled by -44bps to 19.59% in 2025.
  • Its EBT Margin stands at 19.59% for Q3 2025, versus 5.26% for Q2 2025 and 6.46% for Q1 2025.